Lv21
110 积分 2022-10-25 加入
Breaking the immunosuppressive barrier: an armored CAR-M biotechnology with the original M1 phenotype dominance rescues antitumor immunity
1小时前
待确认
Reshaping the metastatic niche with engineered uPA-hunter and VEGF-trap bifunctional nanodecoys for cancer metastasis therapy
1个月前
已完结
Rapid receptor internalization potentiates CD7-targeted lipid nanoparticles for efficient mRNA delivery to T cells and in vivo CAR T-cell engineering
1个月前
已完结
Remodeling the immunosuppressive microenvironment of KARS-LKB1 co-mutant non-small cell lung cancer via targeted PGAM5 siRNA delivery for enhanced immunotherapy
1个月前
已完结
Anti-FAP CAR T cells produced in vivo reduce fibrosis and restore liver homeostasis in metabolic dysfunction–associated steatohepatitis
2个月前
已完结
Stabilizing RNA Nanovaccines with Transformable Hyaluronan Dynamic Hydrogel for Durable Cancer Immunotherapy
3个月前
已完结
CircRNA-based, non-integrated, in vivo panCAR-mediated B cell immune resetting in mouse models and non-human primates
3个月前
已完结
IL-9 signaling redirects CAR T cell fate toward CD8 memory and CD4 cycling states, enhancing antitumor efficacy++
4个月前
已完结
Biomimetic universal CAR-mesenchymal stem cell nanohybrids for anti-tumor therapy
5个月前
已完结
In vivo CAR-T cell engineering in refractory SLE
6个月前
已完结
皖公网安备34019202002308
